LTGO 10-K & 10-Q changes, risk factors and insider trading
Latigo Biotherapeutics, Inc. · Nasdaq · Pharmaceutical Preparations · CIK 2056611 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..
What changed in the latest 10-Q
Comparison not available: Not available: fewer than two 10-Q filings on EDGAR to compare (only one so far)..
LTGO insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 2 Form 4 filings (2 insiders, 1 trade date, 280,000 shares, about $5.0M) and open-market sales in 0 filings. Net open-market shares: 280,000 (purchases minus sales); net value about $5.0M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-10 | 5am Partners Vi, Llc |
Conversion | 2,350,419 | — | — |
| 2026-08-10 | 5am Partners Vi, Llc |
Conversion | 4,975,543 | — | — |
| 2026-08-10 | Sanofi |
Conversion | 494,800 | — | — |
| 2026-08-10 | Sanofi |
Conversion | 177,978 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 938,979 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 3,547,842 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 2,066,857 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 165,519 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 1,027,635 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 3,464,072 | — | — |
| 2026-08-10 | Westlake Biopartners Gp I, Llc |
Conversion | 1,484,401 | — | — |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Conversion | 195,776 | — | — |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Open-market purchase | 140,000 | $18.00 | $2.5M |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Conversion | 742,201 | — | — |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Conversion | 1,125,823 | — | — |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Conversion | 445,320 | — | — |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Conversion | 3,117,664 | — | — |
| 2026-08-10 | Foresite Capital Fund Vi Lp |
Conversion | 296,880 | — | — |
| 2026-08-10 | Tananbaum James B. |
Conversion | 3,117,664 | — | — |
| 2026-08-10 | Tananbaum James B. |
Conversion | 195,776 | — | — |
| 2026-08-10 | Tananbaum James B. |
Open-market purchase | 140,000 | $18.00 | $2.5M |
| 2026-08-10 | Tananbaum James B. |
Conversion | 742,201 | — | — |
| 2026-08-10 | Tananbaum James B. |
Conversion | 1,125,823 | — | — |
| 2026-08-10 | Tananbaum James B. |
Conversion | 296,880 | — | — |
| 2026-08-10 | Tananbaum James B. |
Conversion | 445,320 | — | — |
| 2026-08-10 | Tananbaum James B. |
Conversion | 3,117,664 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 2,066,857 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 165,519 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 1,484,401 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 3,464,072 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 1,027,635 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 938,979 | — | — |
| 2026-08-10 | Seidenberg Beth C |
Conversion | 3,547,842 | — | — |
Well-known investors holding LTGO (13F)
None of the 59 investors we track reported a position in their latest 13F.